Biopharma Stock Alert: Progenics Pharmaceuticals (Nasdaq:PGNX) Announces Pricing of Public Offering of Common Stock
Posted on November 29, 2012 at 09:00 AM EST
TARRYTOWN, N.Y. - November 29, 2012 (Investorideas.com Newswire) Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced today the pricing of an underwritten public offering of 11,000,000 primary shares of its common stock at a public offering price of $2.00 per share.